Teva Pharmaceuticals Industries Ltd. (NYSE: TEVA) shares dropped after the company presented new epidemiology findings on migraine from Israel, indicating that socio-economic factors can lead to migraine underdiagnosis in society. Disparities exist in migraine diagnosis related to socio-economic status A retrospective migraine epidemiology study in Southern Israel, funded by Teva, […]